Evidence map›Paper›PMID 26384312›Full record

ReviewCurrent oncology reports2015

Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.

Ysabella Z A Van Sebille, Romany Stansborough, Hannah R Wardill, Emma Bateman, Rachel J Gibson, Dorothy M Keefe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. The Role of Probiotics in Colorectal Cancer: A Review.Journal of gastrointestinal cancer · 2023
    Review
  11. Could paraprobiotics be a safer alternative to probiotics for managing cancer chemotherapy-induced gastrointestinal toxicities?Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Mechanisms of Chemotherapy-Induced Neurotoxicity.Frontiers in pharmacology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ysabella Z A Van SebilleSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia. ysabella.vansebille@adelaide.edu.au.
Romany StansboroughSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
Hannah R WardillSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
Emma BatemanSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
Rachel J GibsonSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
Dorothy M KeefeSchool of Medicine, University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia.
University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy-induced mucositis is a common condition caused by the breakdown of the mucosal barrier. Symptoms can include pain, vomiting and diarrhoea, which can often necessitate chemotherapy treatment breaks or dose reductions, thus compromising survival outcomes. Despite the significant impact of mucositis, there are currently limited clinically effective pharmacological therapies for the pathology. New emerging areas of research have been proposed to play key roles in the development of mucositis, providing rationale for potential new therapeutics for the prevention, treatment or management of chemotherapy-induced mucositis. This review aims to address these new areas of research and to comment on the therapeutics arising from them.

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsDrug CombinationsFibroblast Growth Factor 7Gastrointestinal TractHumansHyaluronic AcidIntestinal MucosaMucositisPovidonePractice Guidelines as TopicProbioticsR-SpondinsThrombospondinsZinc SulfateAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsDrug CombinationsFibroblast Growth Factor 7GelclairHyaluronic AcidPovidoneRSPO1 protein, humanR-SpondinsThrombospondinsZinc SulfateAnalgesicsAntimicrobialsAntioxidantsBenzydamine hydrochloride (HCl)Cancer side effectsChemotherapy-induced gut toxicityCoating agentsMucositisMucositis treatmentPaliferminProbioticsR-spondin1ToxicityZinc sulphate

Identifiers

PMID26384312
OpenAlexW2174883501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.